FDA Approves UniQure's Hemgenix, First Hemophilia B Gene Therapy For Adults By: Benzinga via Benzinga November 23, 2022 at 08:12 AM EST UniQure N.V.'s(NASDAQ: QURE) partnerCSL Limited(OTC: CSLLY) hasreceived FDA approvalfor Hemgenix ... Read More >> Related Stocks: Bluebird Bio Csl Ltd ADR Uniqure Ord Shs